Hunan Hansen Pharmaceutical Co Ltd (002412) — Cash Flow Reinvestment Rate
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥3.82 Million (capex CN¥3.82 Million ) from operating cash flow of CN¥52.51 Million. Check earnings quality score of Hunan Hansen Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Hansen Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. Explore Hunan Hansen Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Hunan Hansen Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Hunan Hansen Pharmaceutical Co Ltd (002412) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥93.86 Million | CN¥245.38 Million | CN¥11.10 Million | ▲ +48.6% |
| 2024 | 0.26x | CN¥33.67 Million | CN¥130.78 Million | CN¥11.64 Million | ▼ -37.8% |
| 2023 | 0.41x | CN¥66.58 Million | CN¥160.95 Million | CN¥19.48 Million | ▼ -44.7% |
| 2022 | 0.75x | CN¥107.57 Million | CN¥143.81 Million | CN¥11.50 Million | ▼ -42.8% |
| 2021 | 1.31x | CN¥278.17 Million | CN¥212.54 Million | CN¥229.34 Million | ▲ +52.9% |
| 2020 | 0.86x | CN¥138.85 Million | CN¥162.19 Million | CN¥129.08 Million | ▲ +153.7% |
| 2019 | 0.34x | CN¥55.71 Million | CN¥165.11 Million | CN¥35.71 Million | ▼ -42.5% |
| 2018 | 0.59x | CN¥127.73 Million | CN¥217.52 Million | CN¥64.53 Million | ▼ -44.5% |
| 2017 | 1.06x | CN¥113.40 Million | CN¥107.18 Million | CN¥50.20 Million | ▼ -63.0% |
| 2016 | 2.86x | CN¥460.81 Million | CN¥161.16 Million | CN¥44.91 Million | ▲ +64.0% |
| 2015 | 1.74x | CN¥110.83 Million | CN¥63.57 Million | CN¥75.89 Million | ▲ +101.0% |
| 2014 | 0.87x | CN¥73.75 Million | CN¥85.05 Million | CN¥73.75 Million | ▼ -39.1% |
| 2013 | 1.43x | CN¥108.44 Million | CN¥76.09 Million | CN¥108.44 Million | ▲ +19.2% |
| 2012 | 1.20x | CN¥119.87 Million | CN¥100.23 Million | CN¥119.87 Million | ▲ +69.9% |
| 2011 | 0.70x | CN¥37.90 Million | CN¥53.84 Million | CN¥37.90 Million | ▲ +318.6% |
| 2010 | 0.17x | CN¥3.57 Million | CN¥21.24 Million | CN¥3.57 Million | ▼ -66.4% |
| 2009 | 0.50x | CN¥20.55 Million | CN¥41.02 Million | CN¥20.55 Million | ▲ +30.4% |
| 2008 | 0.38x | CN¥13.04 Million | CN¥33.94 Million | CN¥13.04 Million | ▼ -15.6% |
| 2007 | 0.46x | CN¥17.18 Million | CN¥37.75 Million | CN¥17.18 Million | — |